Ceribell (CBLL) Return on Assets (2024 - 2026)

Ceribell (CBLL) posted Return on Assets of 0.0% for Q1 2026, down 19.51% on a QoQ basis from 0.0% in Q4 2025, and little changed year-over-year from 0.0% in Q1 2025.

Ceribell (CBLL) Return on Assets (2024 - 2026) Analysis & Trends

Ceribell's Return on Assets history runs 3 years deep, the most recent figure standing at 0.0% for Q1 2026.

  • Quarterly Return on Assets changed 0.0% year-over-year to 0.0% in Q1 2026, while the trailing twelve-month figure through Mar 2026 was 0.0% (changed 0.0% YoY) and the FY2025 annual result came in at 0.0%, changed 0.0% from the prior year.
  • Return on Assets was 0.0% for Q1 2026 at Ceribell, down from 0.0% in the prior quarter.
  • Across five years, Return on Assets topped out at 0.0% in Q1 2025 and bottomed at 0.0% in Q1 2026.
  • A 3-year average of 0.0% and a median of 0.0% in 2025 frame the typical range for Return on Assets.
  • Peak annual rise in Return on Assets reached 0 bps in 2025, while the deepest fall reached 0 bps in 2025.
  • Ceribell's Return on Assets stood at 0.0% in 2024, then advanced by 9 bps to 0.0% in 2025, then decreased by 20 bps to 0.0% in 2026.
  • Business Quant data shows CBLL's Return on Assets at 0.0% in Q1 2026, 0.0% in Q4 2025, and 0.0% in Q3 2025.

Peer Comparison

# Company Market Cap Enterprise Value Gross Profit (Qtr) ROA (Qtr)
1 Abbott Laboratories 182.32 Bn 175.02 Bn 6.27 Bn 0.00%
2 Stryker 128.75 Bn 125.88 Bn 3.81 Bn 0.00%
3 Medtronic 107.83 Bn 98.61 Bn 6.41 Bn 0.00%
4 Boston Scientific 67.61 Bn 66.15 Bn 3.61 Bn 0.00%
5 Edwards Lifesciences 48.13 Bn 44.45 Bn 1.29 Bn 0.00%
6 Dexcom 28.26 Bn 27.14 Bn 750.30 Mn 0.00%
7 GE HealthCare Technologies 27.78 Bn 25.50 Bn 1.98 Bn 0.00%
8 Smith & Nephew 26.99 Bn 26.41 Bn - 0.00%
9 Koninklijke Philips 23.92 Bn 20.80 Bn 2.07 Bn 0.00%
10 Ceribell 677.56 Mn 536.38 Mn 23.12 Mn 0.00%

Historic Data

Download Data
DateValue
Mar 31, 2026 0.00%
Dec 31, 2025 0.00%
Sep 30, 2025 0.00%
Jun 30, 2025 0.00%
Mar 31, 2025 0.00%
Dec 31, 2024 0.00%